Erasca Confirms Emerging Growth Company Status in 8-K Filing

Ticker: ERAS · Form: 8-K · Filed: Jan 9, 2024 · CIK: 1761918

Complexity: simple

Sentiment: neutral

Topics: regulatory-filing, emerging-growth-company, disclosure

TL;DR

**Erasca is an emerging growth company, meaning less public info for investors.**

AI Summary

Erasca, Inc. filed an 8-K on January 9, 2024, indicating it is an "emerging growth company" as defined by the Securities Act of 1933 and the Securities Exchange Act of 1934. This status allows Erasca to take advantage of certain reduced reporting requirements, which could impact transparency and investor due diligence. For investors, this means Erasca may provide less detailed financial and operational information compared to larger, more established companies, potentially increasing the risk associated with evaluating the stock.

Why It Matters

This filing confirms Erasca's status as an emerging growth company, which means it benefits from reduced regulatory burdens, but also provides less public information for investors to analyze.

Risk Assessment

Risk Level: medium — The emerging growth company status allows for reduced disclosure, which can increase informational risk for investors trying to assess the company's health and prospects.

Analyst Insight

Investors should be aware that Erasca's emerging growth company status means less public information is available, requiring more independent research or a higher tolerance for informational risk when considering an investment.

Key Players & Entities

Forward-Looking Statements

FAQ

What is the primary purpose of Erasca, Inc.'s 8-K filing dated January 9, 2024?

The primary purpose of Erasca, Inc.'s 8-K filing dated January 9, 2024, is to report that it is an "emerging growth company" as defined under the Securities Act of 1933 and the Securities Exchange Act of 1934, as indicated by the checked box next to "Emerging growth company".

On what date was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on January 09, 2024, which is also the date of the report.

What is Erasca, Inc.'s trading symbol and on which exchange is its common stock registered?

Erasca, Inc.'s trading symbol is ERAS, and its Common Stock, $0.0001 par value per share, is registered on the Nasdaq Global Select Market.

What is the business address listed for Erasca, Inc. in this filing?

The business address listed for Erasca, Inc. is 3115 Merryfield Row Suite 300, San Diego, California, 92121.

Does this 8-K filing indicate any simultaneous filing obligations under other provisions, such as Rule 425 under the Securities Act?

No, the 8-K filing indicates that it is not intended to simultaneously satisfy filing obligations under Rule 425 under the Securities Act, Rule 14a-12 under the Exchange Act, Rule 14d-2(b) under the Exchange Act, or Rule 13e-4(c) under the Exchange Act, as all corresponding boxes are unchecked.

Filing Stats: 727 words · 3 min read · ~2 pages · Grade level 11.6 · Accepted 2024-01-09 09:00:57

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 9, 2024, representatives of Erasca, Inc. (the Company) will be presenting at the J.P. Morgan Healthcare Conference and will be attending meetings with investors and analysts during the week in connection with the conference. During the presentation and the meetings, the Company will present the corporate presentation attached as Exhibit 99.1 to this report, which is incorporated herein by reference. The Company’s updated corporate presentation will be posted to the Company’s website, www.erasca.com. The Company plans to use its website to disseminate future updates to its corporate presentation and does not intend to file or furnish a Form 8-K alerting investors each time the presentation is updated. The information set forth in this Item 7.01 is being furnished pursuant to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Exchange Act, whether made before or after the date hereof, except as expressly provided by specific reference in such a filing. By filing this report and furnishing the information in this Item 7.01, the Company makes no admission as to the materiality of Item 7.01 in this report or the presentation available on the Company’s website. The information contained in the presentation is summary information that is intended to be considered in the context of the Company’s filings with the Securities and Exchange Commission (the SEC) and other public announcements that the Company makes, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Erasca, Inc. Corporate Presentation - January 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Erasca, Inc. Date: January 9, 2024 By: /s/ Ebun Garner General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing